Welcome to LookChem.com Sign In|Join Free
  • or
1-Phenoxy-4-(prop-1-en-1-yl)benzene, also known as 4-allylphenyl phenyl ether, is an organic compound characterized by a phenyl group (C6H5) attached to an oxygen atom, which in turn is connected to another phenyl group. The second phenyl ring has an allyl group (prop-1-en-1-yl) attached to the para position (4th carbon). This molecule is a member of the phenyl ether class and exhibits a unique structure with a combination of aromatic and olefinic moieties. It is an important intermediate in the synthesis of various pharmaceuticals, agrochemicals, and other specialty chemicals due to its versatile reactivity and the presence of both electron-rich and electron-deficient sites. The compound is typically synthesized through the reaction of phenol with allyl bromide in the presence of a base, and it is used as a building block in the preparation of more complex molecules, highlighting its significance in organic synthesis.

4974-87-2

Post Buying Request

4974-87-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

4974-87-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 4974-87-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,9,7 and 4 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 4974-87:
(6*4)+(5*9)+(4*7)+(3*4)+(2*8)+(1*7)=132
132 % 10 = 2
So 4974-87-2 is a valid CAS Registry Number.

4974-87-2Downstream Products

4974-87-2Relevant academic research and scientific papers

ISOXAZOLINES AS INHIBITORS OF FATTY ACID AMIDE HYDROLASE

-

Page/Page column 209, (2010/12/18)

The present invention provides isoxazoline FAAH inhibitors of the formula (I): or pharmaceutically acceptable forms thereof, wherein each of G, Ra, Rb, Rc, and Rd are as defined herein. The present invention also provides pharmaceutical compositions comprising a compound of formula (I), or a pharmaceutically acceptable form thereof, and a pharmaceutically acceptable excipient. The present invention also provides methods for treating an FAAH-mediated condition comprising administering a therapeutically effective amount of a compound of formula (I), or pharmaceutically acceptable form thereof, to a subject in need thereof.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 4974-87-2